Integra LifeSciences Holdings Corporation (IART)
USD 22.16
(-3.78%)
USD 22.16
(-3.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 139.95 Million | 264.46 Million | 312.42 Million | 203.83 Million | 373.68 Million | 199.68 Million |
| Net Income | 67.74 Million | 180.55 Million | 169.07 Million | 133.89 Million | 50.2 Million | 60.8 Million |
| Depreciation & Amortization | 123.51 Million | 118.29 Million | 119.83 Million | 116.03 Million | 109.46 Million | 110.73 Million |
| Deferred income taxes | -11.88 Million | -4.58 Million | -2.75 Million | -64.13 Million | -19.04 Million | -8.18 Million |
| Stock-based compensation | 20.14 Million | 27.72 Million | 36.21 Million | 19.59 Million | 21.25 Million | 20.77 Million |
| Change in working capital | -81.57 Million | -39.42 Million | 18.16 Million | -41.31 Million | -14.5 Million | 1.74 Million |
| Other non-cash items | 22.01 Million | -18.1 Million | -28.1 Million | 39.77 Million | 226.31 Million | 13.81 Million |
| Investing Cash Flow | -94.17 Million | -58.58 Million | -161.44 Million | -68.07 Million | -304.72 Million | -49.7 Million |
| Investments in PPE | -66.86 Million | -47.08 Million | -48.08 Million | -63.89 Million | -134.53 Million | -77.74 Million |
| Acquisitions | -5.38 Million | -27.54 Million | -113.44 Million | 3.65 Million | -30.5 Million | 26.7 Million |
| Investment purchases | -32.69 Million | -4.9 Million | -76 Thousand | -7.84 Million | -207.01 Million | - |
| Sales/Maturities of investments | 5.38 Million | 4.9 Million | 76 Thousand | -3.65 Million | 1.58 Million | - |
| Other Investing Activities | 5.38 Million | 16.05 Million | 79 Thousand | 3.65 Million | 65.74 Million | 1.33 Million |
| Financing Cash Flow | -229.92 Million | -251.95 Million | -98.22 Million | 121.62 Million | 64.46 Million | -180.87 Million |
| Debt repayment | -46.62 Million | -107.8 Million | -125.5 Million | -305.5 Million | -246.1 Million | -488.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -275 Million | -149.61 Million | -4.8 Million | -105.07 Million | -6.51 Million | -7.82 Million |
| Common Stock Issuance | 4.31 Million | 5.46 Million | 6.82 Million | 49.79 Million | 6.94 Million | 358.98 Million |
| Other Financing Activities | 87.37 Million | 5.46 Million | 25.25 Million | -78.8 Million | 310.12 Million | 315.74 Million |
| Accounts receivables | 4.59 Million | -33.9 Million | 7.26 Million | 52.1 Million | -9.42 Million | -17.02 Million |
| Accounts payables | -20.22 Million | 17.34 Million | 32.87 Million | -57.51 Million | 14.66 Million | 3.58 Million |
| Inventory | -59.77 Million | -29.12 Million | 5.37 Million | -48.34 Million | -43.3 Million | 8.3 Million |
| Other working capital | -6.16 Million | 6.26 Million | -27.35 Million | 12.44 Million | 23.56 Million | 6.88 Million |
| Cash at beginning of period | 456.66 Million | 513.44 Million | 470.16 Million | 198.91 Million | 138.83 Million | 174.93 Million |
| Cash at end of period | 276.4 Million | 456.66 Million | 513.44 Million | 470.16 Million | 198.91 Million | 138.83 Million |
| Capital Expenditure | -66.86 Million | -47.08 Million | -48.08 Million | -63.89 Million | -134.53 Million | -77.74 Million |
| Effect of forex changes on cash | 3.88 Million | -10.72 Million | -9.47 Million | 13.87 Million | -4.19 Million | -5.02 Million |
| Net cash flow / Change in cash | -180.25 Million | -56.78 Million | 43.28 Million | 271.25 Million | 60.07 Million | -36.09 Million |
| Free Cash Flow | 73.09 Million | 217.38 Million | 264.34 Million | 139.94 Million | 239.15 Million | 121.94 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.69 Million | -12.4 Million | -3.28 Million | 19.83 Million | 67.74 Million | 19.49 Million |
| Depreciation & Amortization | 35.96 Million | 36.77 Million | 30.56 Million | 30.52 Million | 123.51 Million | 30.55 Million |
| Deferred income taxes | -9.04 Million | -1.84 Million | -2.85 Million | -14.84 Million | -11.88 Million | 1.23 Million |
| Stock-based compensation | 4.38 Million | 7.24 Million | 5.59 Million | 5.79 Million | 20.14 Million | 5.45 Million |
| Change in working capital | 22.41 Million | 938 Thousand | -23.35 Million | 10.09 Million | -81.57 Million | -34.06 Million |
| Other non-cash items | -20.53 Million | 80.38 Million | 2 Million | 7.35 Million | 22.01 Million | 4.08 Million |
| Investing Cash Flow | -10.39 Million | -322.19 Million | -53.96 Million | -57.22 Million | -94.17 Million | -7.69 Million |
| Investments in PPE | -29.64 Million | -29.7 Million | -15.46 Million | -24.53 Million | -66.86 Million | -13.07 Million |
| Acquisitions | - | -281.99 Million | - | - | -5.38 Million | - |
| Investment purchases | - | -10.49 Million | -38.5 Million | -32.69 Million | -32.69 Million | - |
| Sales/Maturities of investments | 19.25 Million | - | - | - | 5.38 Million | - |
| Other Investing Activities | - | -10.49 Million | -38.5 Million | -32.69 Million | 5.38 Million | 5.38 Million |
| Financing Cash Flow | -19.91 Million | -93.74 Million | 358.67 Million | -6.89 Million | -229.92 Million | -49.65 Million |
| Debt repayment | -387.14 Million | -31.74 Million | -355.4 Million | -6.8 Million | -46.62 Million | -56.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 3.12 Million | -50 Million | -3.12 Million | -314 Thousand | -275 Million | -125 Million |
| Common Stock Issuance | -6.39 Million | - | 6.39 Million | 225 Thousand | 4.31 Million | 655 Thousand |
| Other Financing Activities | 370.5 Million | -12 Million | -3.12 Million | -314 Thousand | 87.37 Million | 131.48 Million |
| Accounts receivables | 28.75 Million | -6.71 Million | 16.82 Million | -457 Thousand | 4.59 Million | 224 Thousand |
| Accounts payables | 6.82 Million | 15.07 Million | -19.21 Million | 1.91 Million | -20.22 Million | -6.24 Million |
| Inventory | -10.3 Million | 1.74 Million | -19.02 Million | -16.42 Million | -59.77 Million | -15.79 Million |
| Other working capital | 10.65 Million | -9.15 Million | -1.49 Million | 25.06 Million | -6.16 Million | -12.25 Million |
| Cash at beginning of period | 215.23 Million | 591.9 Million | 276.4 Million | 273.73 Million | 456.66 Million | 309.19 Million |
| Cash at end of period | 215.15 Million | 215.23 Million | 591.9 Million | 276.4 Million | 276.4 Million | -35.46 Million |
| Capital Expenditure | -29.64 Million | -29.7 Million | -15.46 Million | -24.53 Million | -66.86 Million | -13.07 Million |
| Effect of forex changes on cash | 7.74 Million | -1.12 Million | -4.96 Million | 8.03 Million | 3.88 Million | -4.87 Million |
| Net cash flow / Change in cash | -79 Thousand | -376.67 Million | 315.5 Million | 2.67 Million | -180.25 Million | -344.65 Million |
| Free Cash Flow | -7.16 Million | 10.69 Million | 291 Thousand | 34.21 Million | 73.09 Million | 13.69 Million |
CPAC
4378
PVSP
9969
0623
102940